475830 — Orum Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩2tn
- KR₩2tn
- KR₩24m
Annual cashflow statement for Orum Therapeutics, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | — | -63,319 | 68,217 | -5,740 | -41,969 |
| Depreciation | |||||
| Non-Cash Items | — | 22,602 | 26,100 | -701 | -8,014 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -24,645 | -1,665 | -1,845 | -7,709 | 10,697 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -24,645 | -41,092 | 94,244 | -11,282 | -35,989 |
| Capital Expenditures | -942 | -796 | -1,126 | -1,264 | -696 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -30,060 | 27,498 | -1,299 | -97,197 | -27,628 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -31,002 | 26,701 | -2,426 | -98,460 | -28,324 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 59,869 | -1,394 | 23,573 | -838 | 48,679 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 4,252 | -15,866 | 115,383 | -106,959 | -15,635 |